Literature DB >> 11535879

Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers.

P Terry1, J Lagergren, H Hansen, A Wolk, O Nyrén.   

Abstract

The incidence of adenocarcinoma of the oesophagus has increased rapidly in recent decades. In order to appreciate the potential for prevention by means of dietary modification, we estimated the aetiological fractions and the increments in absolute risk attributable to low intake of fruit and vegetables for adenocarcinoma and squamous cell carcinoma of the oesophagus and for adenocarcinoma of the gastroesophageal junction. We conducted a nationwide population-based case-control study in Sweden, with participation of 608 cases and 815 controls. We used unconditional logistic regression to estimate relative risks, from which we calculated aetiological fractions. Individuals in the highest exposure quartile (median 4.8 servings/day) versus the lowest (median 1.5 servings/day) showed approximately 50% lower risk of oesophageal adenocarcinoma and 40% lower risk of oesophageal squamous cell carcinoma, but no risk reduction for gastric cardia adenocarcinoma. Approximately 20% of oesophageal adenocarcinoma, and likewise squamous cell carcinoma, in Sweden was attributed to consuming less than three servings of fruit and vegetables per day. A very large number of individuals (over 25,000) would need to increase their fruit and vegetable consumption moderately in order to prevent one oesophageal cancer per year. Moderate relative risk reductions translate into weak absolute risk reductions for oesophageal cancers in Sweden.

Entities:  

Mesh:

Year:  2001        PMID: 11535879     DOI: 10.1097/00008469-200108000-00010

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  36 in total

1.  Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis.

Authors:  Deirdre P Cronin-Fenton; Liam J Murray; David C Whiteman; Chris Cardwell; Penelope M Webb; Susan J Jordan; Douglas A Corley; Linda Sharp; Jesper Lagergren
Journal:  Eur J Cancer       Date:  2010-04-22       Impact factor: 9.162

Review 2.  Risk factors for neoplastic progression in Barrett's esophagus.

Authors:  Elizabeth F Wiseman; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

3.  Chemoprevention of esophageal adenocarcinoma.

Authors:  Julian A Abrams
Journal:  Therap Adv Gastroenterol       Date:  2008-07       Impact factor: 4.409

Review 4.  Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?

Authors:  J Lagergren
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

5.  Adenocarcinoma of the stomach: a review.

Authors:  James M McLoughlin
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-10

6.  Risk factors for the gastric cardia cancer: a case-control study in Fujian Province.

Authors:  Lin Cai; Zong-Li Zheng; Zuo-Feng Zhang
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

7.  Vegetable and fruit intakes and risk of Barrett's esophagus in men and women.

Authors:  Olivia M Thompson; Shirley A A Beresford; Elizabeth A Kirk; Thomas L Vaughan
Journal:  Am J Clin Nutr       Date:  2009-01-14       Impact factor: 7.045

8.  Effects of dietary fiber, fats, and meat intakes on the risk of Barrett's esophagus.

Authors:  Ai Kubo; Gladys Block; Charles P Quesenberry; Patricia Buffler; Douglas A Corley
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

9.  A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status.

Authors:  W J Louwman; M J Aarts; S Houterman; F J van Lenthe; J W W Coebergh; M L G Janssen-Heijnen
Journal:  Br J Cancer       Date:  2010-10-26       Impact factor: 7.640

10.  Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005.

Authors:  M B Cook; W-H Chow; S S Devesa
Journal:  Br J Cancer       Date:  2009-08-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.